Adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema in Taiwan: a comparative cohort study
In comparison to ranibizumab, the intravitreal use of aflibercept was associated with a greater risk of adverse renal events. These findings provide a solid foundation for future studies to validate these results further.
Authors
- Wan‐Ju Annabelle Lee (ORCID: https://orcid.org/0000-0002-9972-8899)
- Miyuki Hsing‐Chun Hsieh (ORCID: https://orcid.org/0000-0002-7995-7408)
- Tzu-Chi Liao
- Edward Chia‐Cheng Lai (ORCID: https://orcid.org/0000-0002-5852-7652)
- Swu‐Jane Lin (ORCID: https://orcid.org/0000-0003-0953-9988)
- Shih‐Chieh Shao (ORCID: https://orcid.org/0000-0003-4867-6686)
Institutions
- University of Illinois Chicago (US)
- Keelung Chang Gung Memorial Hospital (TW)
- Chi Mei Medical Center (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- British Journal of Ophthalmology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1136/bjo-2024-325509
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12
Funders
- Chi Mei Medical Center